Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 28 most recent Form 4 transactions.
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 48,679 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 11,096 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 382 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,421 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 26,832 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 3,059 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 1, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 2,000 | $52.88 | $105.8K | -6.3% | Open the original filing on SEC.gov |
| Jun 30, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 193 | $23.87 | $4.6K | +0.6% | Open the original filing on SEC.gov |
| Jun 20, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 875 | $54.59 | $47.8K | -2.7% | Open the original filing on SEC.gov |
| Jun 16, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 2,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 16, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 500 | $55.09 | $27.5K | -1.5% | Open the original filing on SEC.gov |
| Jun 16, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 1,500 | $53.82 | $80.7K | -4.3% | Open the original filing on SEC.gov |
| Jun 16, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 2,000 | $19.87 | $39.7K | +6.1% | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 919 | $54.00 | $49.6K | -2.7% | Open the original filing on SEC.gov |
| Jun 2, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 2, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 100 | $51.04 | $5.1K | -0.3% | Open the original filing on SEC.gov |
| Jun 2, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 3,300 | $50.46 | $166.5K | -8.9% | Open the original filing on SEC.gov |
| Jun 2, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 600 | $49.40 | $29.6K | -1.6% | Open the original filing on SEC.gov |
| Jun 2, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 4,000 | $19.87 | $79.5K | +11.9% | Open the original filing on SEC.gov |
| May 22, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 4,000 | $50.00 | $200K | -10.7% | Open the original filing on SEC.gov |
| May 22, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 4,000 | $44.37 | $177.5K | +11.9% | Open the original filing on SEC.gov |
| May 7, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 8,000 | — | — | — | Open the original filing on SEC.gov |
| May 7, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 3,299 | $42.76 | $141.1K | -9.0% | Open the original filing on SEC.gov |
| May 7, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 4,701 | $42.31 | $198.9K | -11.3% | Open the original filing on SEC.gov |
| May 7, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 8,000 | $19.87 | $159K | +23.9% | Open the original filing on SEC.gov |